United States: DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 - Polsinelli LLP

Mondaq

16 Oct 2023 0 shares 1 views

United States: DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 - Polsinelli LLP

Mondaq

Published 16 Oct 2023

On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) issued a Second Temporary Rule further extending the ability to prescribe...

Full Article

United States: Tele-Prescribing Flexibilities Extended Again In Second Temporary Rule - Sheppard Mullin Richter & Hampton

This month, the Drug Enforcement Administration ("DEA"), in conjunction with the Substance Abuse and Mental Health Services..

Mondaq 19 Oct 2023

United States: Extension Extended: DEA Continues Telemedicine Prescription Flexibilities Through 2024 - Bass, Berry & Sims

On October 6, the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA)..

Mondaq 09 Oct 2023

United States: DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 - Polsinelli LLP

United States: DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 - Polsinelli LLP

You might like

Related news coverage

United States: Tele-Prescribing Flexibilities Extended Again In Second Temporary Rule - Sheppard Mullin Richter & Hampton

United States: Extension Extended: DEA Continues Telemedicine Prescription Flexibilities Through 2024 - Bass, Berry & Sims

Advertisement